In humanized transgenic mouse models of MECP2 duplication syndrome (MDS)(35), we demonstrated that excessive silencing of MECP2 in Tg1 mice (which expresses twice the endogenous MeCP2 levels) leads to mixed behavioral outcomes that could indicate toxicity, while moderate silencing does not produce the same effects. Here, MECP2 is linked to myelodysplastic syndrome.